Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
endostatin (endostar) (1 trial)
Carcinoma (Phase 3)
Nasopharyngeal Carcinoma (Phase 3)
Trials (1 total)
Trial APIs (1 total)